Our Pricing

Order Wegovy Private Prescription - No GP Referral

Published on: June 03, 2026

Need to order Wegovy private prescription UK without waiting for a GP appointment? At Cured Pharmacy, our UK-registered prescribers assess your suitability online in under 3 minutes, with Wegovy available from £79.00 and discreet next-day delivery across the UK.

How to Order Wegovy Private Prescription Without GP Referral

Ordering a private Wegovy prescription through Cured Pharmacy eliminates the need for a traditional GP referral. Our streamlined process connects you directly with UK-registered prescribers who specialise in weight management treatments, conducting thorough clinical assessments entirely online [1].

After completing your free consultation questionnaire, a UK prescriber reviews your medical history, current medications, and weight loss goals. If Wegovy is clinically appropriate, your prescription is issued electronically and dispensed by our GPhC-registered pharmacy team led by superintendent pharmacist Tarun Kumar (GPhC 2233073). Most patients receive their medication within 24-48 hours via discreet Royal Mail delivery.

This private prescription pathway is fully compliant with MHRA regulations and follows the same clinical safety standards as NHS prescribing, but without the waiting times or need to visit your local surgery.

Who Can Get a Private Wegovy Prescription?

Wegovy is licensed in the UK for adults with a BMI of 30 or above, or BMI 27 or above with at least one weight-related health condition such as type 2 diabetes, hypertension, or obstructive sleep apnoea [2]. Our prescribers assess each patient individually, considering medical history, current medications, and contraindications including personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2.

Patients already taking other GLP-1 receptor agonists, those with severe gastrointestinal disease, or individuals with uncontrolled thyroid disorders may not be suitable candidates. Your online consultation ensures these factors are properly evaluated before any prescription is issued.

Wegovy Dosing Schedule and What to Expect

Wegovy follows a carefully structured dose escalation protocol designed to minimise gastrointestinal side effects while optimising weight loss outcomes. Treatment begins with a 0.25mg weekly injection for four weeks, gradually increasing monthly through 0.5mg, 1mg, and 1.7mg doses before reaching the maintenance dose of 2.4mg weekly [3].

This gradual titration allows your body to adapt to semaglutide's effects on gastric emptying and appetite regulation. In the landmark STEP 1 trial, patients on the 2.4mg maintenance dose achieved an average 14.9% body weight reduction over 68 weeks, compared to 2.4% with placebo [3]. Most patients notice reduced appetite and increased satiety within the first 2-4 weeks, though maximum weight loss typically occurs between months 6-12.

Each Wegovy pen is pre-filled and administered subcutaneously once weekly, on the same day each week. Injection sites rotate between abdomen, thigh, or upper arm. Our pharmacy team provides detailed administration guidance with every prescription, and your prescriber monitors progress through optional follow-up consultations.

Wegovy vs Mounjaro: Comparing UK Weight Loss Injections

Both Wegovy and Mounjaro are once-weekly injectable medications licensed by the MHRA for chronic weight management, but they work through different mechanisms. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics one natural gut hormone, while Mounjaro contains tirzepatide, the first dual GIP/GLP-1 receptor agonist activating two complementary pathways [4].

Head-to-head trial data suggests tirzepatide produces greater average weight loss — the SURPASS-2 trial showed 15mg tirzepatide resulted in 11.2kg greater weight reduction compared to 1mg semaglutide over 40 weeks [4]. However, individual response varies considerably, and Wegovy's longer track record and lower starting price make it an appropriate first-line option for many patients.

Your UK prescriber considers multiple factors when recommending between these treatments, including your weight loss goals, budget, previous treatment responses, and specific medical conditions. Some patients transition between medications based on tolerability or efficacy, and our clinical team supports these adjustments through ongoing prescriber consultations.

Cost Comparison: Private Prescription Pricing

At Cured Pharmacy, Wegovy pricing starts from £79.00 per pen, with transparent upfront costs shown before your consultation begins. We guarantee the lowest prices in the UK for genuine MHRA-licensed medications, with no hidden consultation fees or subscription requirements.

Treatment duration varies by individual, but most patients require 12-18 months to achieve optimal results, followed by ongoing maintenance therapy. Our prescribers discuss realistic timelines and total treatment costs during your initial assessment, ensuring you can make informed decisions about your weight management journey.

Managing Wegovy Side Effects: Clinical Insights

The most common side effects of Wegovy are gastrointestinal, affecting up to 44% of patients in clinical trials. Nausea, diarrhoea, vomiting, constipation, and abdominal discomfort typically occur during dose escalation phases and usually diminish within 4-8 weeks as tolerance develops [3].

To minimise these effects, eat smaller, more frequent meals, avoid high-fat foods, stay well-hydrated, and take your injection on the same day each week. If side effects persist or worsen, your prescriber may slow the dose escalation schedule or recommend temporary dose reduction. Severe persistent vomiting or signs of pancreatitis (severe abdominal pain radiating to the back) require immediate medical attention.

Less common but serious risks include gallbladder problems, acute kidney injury (usually secondary to dehydration from vomiting), and increased heart rate. Our prescribers screen for contraindications during your assessment and provide detailed safety information with every prescription. Regular monitoring through follow-up consultations helps identify any concerns early.

Combining Wegovy with Diet and Exercise for Optimal Results

Wegovy is licensed as an adjunct to a reduced-calorie diet and increased physical activity, not as a standalone solution [2]. Clinical trial participants followed structured lifestyle interventions alongside medication, and real-world outcomes depend significantly on sustained behavioural changes.

A moderate calorie deficit of 500-750 calories daily, combined with 150-300 minutes of moderate-intensity exercise weekly, optimises weight loss while preserving lean muscle mass. Wegovy's appetite-suppressing effects make adhering to these targets considerably easier than diet and exercise alone, but the medication works synergistically with lifestyle modifications rather than replacing them.

Our prescribers provide personalised guidance on sustainable dietary patterns and activity levels appropriate for your current fitness level and medical conditions. Many patients benefit from concurrent support from registered dietitians or exercise physiologists, though this is not mandatory for prescription approval.

Long-Term Weight Maintenance After Wegovy

The STEP 4 trial demonstrated that patients who discontinued Wegovy after 20 weeks regained approximately two-thirds of their lost weight over the following year, while those continuing treatment maintained their weight loss [5]. This highlights the importance of viewing Wegovy as a long-term chronic disease management tool rather than a short-term intervention.

Current NICE guidance supports ongoing treatment for patients who achieve clinically meaningful weight loss (5% or more at 6 months) and continue to benefit from therapy. Your prescriber reviews progress at regular intervals to assess whether continued treatment remains appropriate and cost-effective for your individual circumstances.

Why Choose Cured Pharmacy for Your Wegovy Prescription

As a fully registered UK pharmacy (GPhC 9012511), Cured Pharmacy dispenses only genuine MHRA-licensed Wegovy pens sourced directly from UK-authorised wholesalers. Every medication is stored in temperature-controlled conditions and shipped in insulated packaging to maintain the cold chain required for semaglutide stability.

Our transparent pricing model shows exact costs before you begin your consultation, with no hidden fees or mandatory subscription plans. The £79.00 starting price includes prescriber assessment, medication, and discreet delivery — everything you need to begin treatment. We also offer flexible follow-up consultations with the same prescribing team who approved your initial prescription, ensuring continuity of care throughout your weight loss journey.

With next-day delivery available across the UK and dedicated pharmacist support via phone during business hours, we combine the convenience of online prescribing with the clinical expertise and regulatory oversight you'd expect from a traditional high-street pharmacy. Our superintendent pharmacist Tarun Kumar oversees every prescription dispensed, maintaining the highest standards of pharmaceutical care.

Scientific References

1. Medicines and Healthcare products Regulatory Agency. (2023). Public Assessment Report: Wegovy 2.4 mg solution for injection in pre-filled pen. GOV.UK. https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency [accessed 13 August 2026]
2. Novo Nordisk. (2024). Wegovy 2.4mg Solution for Injection in Pre-filled Pen: Summary of Product Characteristics. Electronic Medicines Compendium. https://www.medicines.org.uk/emc/product/13799 [accessed 13 August 2026]
3. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
4. Frías, J. P., et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine, 385(6), 503–515. https://doi.org/10.1056/NEJMoa2107519 [accessed 13 August 2026]
5. Rubino, D., et al. (2021). Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA, 325(14), 1414–1425. https://doi.org/10.1001/jama.2021.3224 [accessed 13 August 2026]
6. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
7. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
8. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.